Cleared Traditional

K190090 - DynoSense Vital Sign Measuring System

K190090 is an FDA 510(k) clearance for DynoSense Vital Sign Measuring System, manufactured by Dynosense Corp.. The device is a Class 2 Cardiovascular device with product code MWI cleared through the Traditional 510(k) pathway after a 197-day FDA review.

K190090 · Dynosense Corp. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2019
Decision
197d
Days
Class 2
Risk

K190090 is an FDA 510(k) clearance for the DynoSense Vital Sign Measuring System. Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Dynosense Corp. (Los Gatos, US). The FDA issued a Cleared decision on August 2, 2019 after a review of 197 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Dynosense Corp. devices

FDA 510(k) Submission Details - K190090

510(k) Number K190090 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 17, 2019
Decision Date August 02, 2019
Days to Decision 197 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
72d slower than avg
Panel avg: 125d · This submission: 197d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MWI Device Classification - Class 2, Special Controls

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 253
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K190090.
LifeWindow LW8 Lite
K183687 · Digicare Biomedical Technology, Inc. · Sep 2019
PeraMobile and PeraWatch
K183370 · Perahealth, Inc. · Sep 2019
B.O.L.T Base Unit, B.O.L.T Non-Invasive Blood Pressure (NIBP) Cuff, B.O.L.T Infared Radiation Energy Technology(IRT) Thermometer probe, B.O.L.T Pulse Oximeter(SPO2) probe, B.O.L.T Gluchobin Blood Glucose, Total Cholesterol and Hemoglobin meter
K182401 · Amzetta Technologies Private Limited · Aug 2019
Nihon Kohden SVM-7200 Series Vital Signs Monitor
K190468 · Nihon Kohden Corporation · May 2019
Masimo Rad-97 and Accessories
K183697 · Masimo Corporation · May 2019
Stasis Monitoring System
K183634 · Stasis Labs, Inc. · Apr 2019